Steamboat Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Steamboat Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-46,999	Closed	-$20.8M	–	57
2020 Q3	$20.8M	Sell	46,999 -583	-1%	-$241K	3.38%	8
2020 Q2	$17.2M	Sell	47,582 -15,322	-24%	-$5.14M	3.21%	11
2020 Q1	$17.8M	Buy	62,904 +5,274	+9%	+$1.66M	3.5%	8
2019 Q4	$18.7M	Sell	57,630 -1,049	-2%	-$318K	5.3%	5
2019 Q3	$17.1M	Sell	58,679 -16,550	-22%	-$4.74M	5.27%	4
2019 Q2	$22.1M	Buy	75,229 +598	+0.8%	+$165K	5.8%	3
2019 Q1	$20.4M	Sell	74,631 -19,233	-20%	-$4.79M	7.3%	2
2018 Q4	$21M	Buy	93,864 +17,576	+23%	+$4.12M	8.97%	2
2018 Q3	$18.6M	Buy	76,288 +963	+1%	+$222K	8.11%	2
2018 Q2	$15.6M	Buy	+75,325	New	+$16M	8.31%	4

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Steamboat Capital Partners's TMO Position: Q4 2020 in Review

Steamboat Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q4 2020, closing a stake of 46,999 shares — an estimated $20.8M sold.

Steamboat Capital Partners first reported a position in TMO in Q2 2018 and held it in 10 quarters. The position peaked at $22.1M in Q2 2019. 2,030 funds tracked by Wall St. Rank hold TMO as of Q4 2020.

Steamboat Capital Partners reported no remaining Thermo Fisher Scientific position as of Q4 2020 after selling out during the quarter.
Steamboat Capital Partners sold 46,999 Thermo Fisher Scientific shares in Q4 2020, an estimated $20.8M.
Steamboat Capital Partners first reported a position in Thermo Fisher Scientific in Q2 2018 and held it in 10 quarters.
Steamboat Capital Partners's Thermo Fisher Scientific position peaked at $22.1M in Q2 2019.
2,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2020.

Based on Steamboat Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.